| 序号 | 名称 | 港股代码 | ADR换算价(HKD) | 较港股升跌 | 较港股升跌% | AD ADR最新价(美元) | | --- | --- | --- | --- | --- | --- | --- | | 1 | 腾讯控股 | 0 00700 | 545.065 | -3.935 | -0.72% | 69.440 | | 2 | 阿里巴巴-W | 09988 | 115.171 | -1.929 | -1.65% | 117.380 | | 3 | 建设银行 | 00939 | 8.136 | -0.054 | -0.66% | 20.730 | | 4 | 汇丰控股 | 00005 | 96.517 | -0.433 | -0.45% | 61.480 | | 5 | 小米集团-W | 01810 | 54.365 | -0.385 | -0.70% | 34.630 | | 6 | 友邦保险 | 01299 | 73.804 | -0.446 | -0.60% | 37.610 | | 7 | 美团-W | 03690 | 121.823 | -5.577 | -4.38% | 31. ...

7月30日，金融监管总局发布批复信息，核准余宏友邦人寿董事、总经理的任职资格。 余宏出生于1968年10月，在加入友邦之前，曾在平安人寿任职长达27年，历任平安人寿总部保费部收费企划室主任，平安人寿 董事长办公室主任、副总经理，平安人寿重庆分公司副总经理、总经理，平安人寿总经理助理等职务。 2017年3月，余宏出任平安人寿总经理，成为平安人寿首位女性总经理；2018年11月起，兼任平安人寿首席执行官、寿险执行 委员会主任。2024年10月，余宏退休后返聘任职期满，不再担任平安人寿总经理等相关职务。 2024年11月，余宏转战友邦人寿，拟任总经理一职，并全面负责公司战略规划与实施，以及日常运营等工作。 与此同时，友邦人寿原总经理兼首席执行官张晓宇升任友邦保险区域首席执行官，负责友邦保险在中国内地、韩国和越南的业 务。今年1月，张晓宇获批出任友邦人寿董事长。 随后，今年6月，友邦保险宣布，独立非执行主席及独立非执行董事谢仕荣将于9月底退任。现年67岁的杜嘉祺将"回归"接任， 任期于10月1日起生效。 管理层接连调整的背后，是友邦保险在中国内地市场的加速扩张。2020年，友邦保险获批"分改子"，将友邦保险上海分公司 ...

从中证沪港深500金融指数持仓的市场板块来看，香港证券交易所占比51.39%、上海证券交易所占比 42.37%、深圳证券交易所占比6.23%。 从中证沪港深500金融指数持仓样本的行业来看，银行占比60.34%、保险占比19.79%、资本市场占比 18.75%、其他金融占比1.12%。 资料显示，该指数系列样本每半年调整一次，样本调整实施时间分别为每年6月和12月的第二个星期五 的下一交易日。权重因子随样本定期调整而调整，调整时间与指数样本定期调整实施时间相同。在下一 个定期调整日前，权重因子一般固定不变。特殊情况下将对该指数系列样本进行临时调整。当样本退市 时，将其从指数样本中剔除。样本公司发生收购、合并、分拆等情形的处理，参照计算与维护细则处 理。当中证沪港深500指数、中证沪港深互联互通中小综合指数和中证沪港深互联互通综合指数样本发 生变动时，将进行相应调整。 金融界7月30日消息，A股三大指数收盘涨跌不一，中证沪港深500金融指数(沪港深500金融，H30464) 报2380.79点。 数据统计显示，中证沪港深500金融指数近一个月上涨2.83%，近三个月上涨15.09%，年至今上涨 17.89%。 ...

Core Viewpoint - The National Financial Supervision Administration of Zhuhai has approved the address change for AIA Life Insurance Co., Ltd. Guangdong Branch's Zhuhai Central Sub-branch [1] Group 1 - AIA Life Insurance Co., Ltd. Guangdong Branch's Zhuhai Central Sub-branch will change its business location to: 68 Qianhebei Road, Unit 2801-01, 09, 10, Xiangzhou District, Zhuhai City, Guangdong Province [1] - The company is required to handle the change and obtain a new license in accordance with relevant regulations [1]

Group 1 - The core viewpoint of the article is that 130 Chinese companies made it to the 2025 Fortune Global 500 list, with 7 insurance companies included, and most of them improved their rankings compared to the previous year [1][2][3] Group 2 - The 7 Chinese insurance companies on the list are China Life Insurance Group (ranked 45), Ping An Insurance Group (ranked 47), People's Insurance Group of China (ranked 141), China Pacific Insurance (ranked 251), Taikang Insurance Group (ranked 334), AIA Group (ranked 417), and New China Life Insurance (ranked 498) [2][3] - China Life's revenue for 2024 is approximately $160.28 billion, while Ping An's is about $158.63 billion, People's Insurance's is around $86.48 billion, China Pacific's is about $56.16 billion, Taikang's is approximately $45.46 billion, AIA's is around $37.61 billion, and New China's is about $32.29 billion [2][3] Group 3 - China Life improved its ranking from 59 to 45, Ping An from 53 to 47, People's Insurance rose 17 places to 141, and China Pacific saw the largest increase of 80 places to 251 [3] - Taikang Insurance has been on the list for eight consecutive years, moving up 47 places to 334, AIA improved by 29 places to 417, and New China returned to the list at 498 after being absent the previous year [3] Group 4 - The total revenue of the companies on the Fortune Global 500 list is approximately $41.7 trillion, which is more than one-third of the global GDP, showing a growth of about 1.8% from the previous year [3] - The threshold for inclusion in the list increased from $32.1 billion to $32.2 billion, and the total net profit of the listed companies grew by approximately 0.4% to around $2.98 trillion [3]

Summary of Key Points Core Viewpoint - The report highlights the top short-selling stocks in the market, indicating significant short-selling activity and potential investor sentiment towards these companies. Group 1: Top Short-Selling Ratios - JD Health (86618) has the highest short-selling ratio at 100.00% [1][2] - Hang Seng Bank (80011) follows with a short-selling ratio of 88.44% [1][2] - SenseTime (80020) has a short-selling ratio of 76.25% [1][2] Group 2: Top Short-Selling Amounts - Xiaomi Group (01810) leads in short-selling amount with 2.209 billion [1][2] - Tencent Holdings (00700) has a short-selling amount of 0.955 billion [1][2] - WuXi AppTec (02359) reports a short-selling amount of 0.698 billion [1][2] Group 3: Top Short-Selling Deviations - Hang Seng Bank (80011) has the highest deviation value at 48.82% [1][2] - JD Health (86618) follows with a deviation value of 45.78% [1][2] - Uni-President China (00220) has a deviation value of 33.70% [1][2]

Group 1 - The China Insurance Industry Association has lowered the pricing interest rate (PIR) benchmark by 14 basis points to 1.99%, which is 51 basis points lower than the current traditional product rate of 2.5% [1] - This adjustment aligns with market expectations and reflects a downward trend in market interest rates anticipated by the second quarter of 2025 [1] - Major insurance companies have adjusted the pricing interest rates for traditional, participating, and universal products to 2.0%, 1.75%, and 1.0% respectively, indicating a regulatory push towards participating products to mitigate interest spread risk [1] Group 2 - The adjustment in pricing interest rates may signal the end of the golden era for traditional increasing death benefit whole life insurance (IWLP), which, despite consumer popularity, poses significant interest rate risks for insurance companies [1] - Participating products are becoming more attractive, with the Hong Kong market showing projected returns of 6% to 6.5%, benefiting both the Hong Kong and mainland markets [1] - UBS estimates that the actual internal rate of return (IRR) for policyholders with a 2.0% pricing interest rate on traditional products is only between 1.6% and 1.9%, making long-term holding (over 10 years) less appealing [1] Group 3 - As insurance companies accelerate the transition to participating products, the interest rate sensitivity of new business value is expected to decline significantly in the first half of 2025 [2] - The increased proportion of participating products may lead to a higher allocation of equity assets (such as stocks) due to their higher risk tolerance in investment accounts [2] - AIA China (01299) is positioned advantageously in the transition to participating products, with a strong investment capability and a higher average comprehensive investment return rate of 4.8% from 2021 to 2024, surpassing the industry average of 4% [2]

AIA Group (1299.HK) 1H25 Preview Summary Company Overview - AIA Group is set to report its 2Q/1H25 results on August 21, 2025, before market opening [1] Key Financial Metrics - **Value of New Business (VONB)**: Expected to grow by 14% year-over-year (yoy) to US$2,809 million in 1H25, with a faster growth rate of 16% yoy in 2Q25 compared to 13% in 1Q25 [7][12] - **Net Free Surplus Generation (NFSG)**: Anticipated to increase by 9% yoy to US$2.442 billion in 1H25, up from a 2% increase in FY24 [9][12] - **Operating Profit After Tax (OPAT)**: Expected to rise by 3% yoy to US$3.49 billion in 1H25, slower than the 6% growth in FY24 [8][12] - **Embedded Value (EV)**: Projected to increase by 2% to US$70.1 billion in 1H25 [10][12] Market Performance Insights - **Hong Kong**: Anticipated to be the main driver of VONB growth, with a projected increase of 23% yoy in 1H25 [6][11] - **Mainland China**: Expected to see a decline of 6% yoy in VONB for 1H25, primarily due to negative impacts from economic assumption changes [6][11] - **Thailand**: Forecasted to show a decline in VONB in 2Q25 due to demand being pulled forward ahead of regulatory changes [6][11] Strategic Focus Areas - Emphasis on underlying growth drivers such as: 1. Growth in mainland China and newly established regions 2. Sales momentum in Hong Kong 3. Factors contributing to NFSG growth, including operational variances and capital efficiency improvements [2] Valuation and Target Price - The target price has been adjusted to HK$83 from HK$90, based on a 1.4X FY26E P/EV, implying an 18% upside [3] - The medium-term Return on Embedded Value (ROEV) is estimated at 14.7%, with a Cost of Equity (COE) of 11.2% and a long-term growth rate of 2% [3][24] Additional Insights - The company does not expect any additional buybacks for FY25, suggesting a focus on growth rather than capital return strategies [2] - The anticipated increase in interim dividends per share (DPS) is 8% yoy to US$0.062 [10][12] - AIA's valuation methodology has shifted from a discounted model-based valuation to a P/EV multiple approach, reflecting a greater emphasis on capital generation capabilities [18][23] Conclusion - AIA Group is positioned for growth in 1H25, with strong performance expected in Hong Kong, while facing challenges in mainland China. The strategic focus on underlying growth drivers and adjustments in valuation methodology indicate a proactive approach to navigating market dynamics.

Core Viewpoint - The 2024 life insurance industry has seen a decline in employee compensation and a historical low in the salary-to-premium ratio, indicating potential challenges in operational efficiency and profitability [2][14]. Group 1: Salary and Premium Ratio Analysis - In 2024, the total employee compensation in the life insurance industry was 108.5 billion yuan, a decrease of 4.6% year-on-year, with a salary-to-premium ratio of 3.4%, down 0.5 percentage points, marking a 15-year low [2][14]. - The "TOP7+1" companies (including major players like China Life and Ping An) had a salary-to-premium ratio of 3.3%, which is significantly lower than that of small and medium-sized insurance companies, which stood at 3.7% [17][18]. - The average salary-to-premium ratio for 70 life insurance companies over the past five years was 4.0%, with a median of 4.9%, and 11 companies exceeding 10% [5][28]. Group 2: Impact on Return on Equity (ROE) - The salary-to-premium ratio has a significant negative impact on a company's ROE, with each 1 percentage point increase in the ratio leading to a 0.37 percentage point decrease in ROE [24][25]. - The empirical model constructed to analyze this relationship included variables such as company size and channel type, confirming the negative correlation between salary-to-premium ratio and ROE [24][25]. Group 3: Historical Trends - The salary-to-premium ratio has shown a declining trend since 2018, with a notable acceleration in the decline for small and medium-sized insurance companies since 2019 [16][18]. - The ratio increased from 4.2% in 2010 to a peak of 5.3% in 2015, followed by a steady decline to the current levels [16][18]. Group 4: Employee Compensation Insights - The life insurance industry employed approximately 345,000 individuals in 2023, with an average compensation and benefits level of 330,000 yuan [10][22]. - The fluctuation in employee numbers has shown a slight decline, while average compensation has seen minor increases over recent years [10][22].

Market Performance - The Hong Kong stock market showed mixed performance with the Hang Seng Index rising by 0.68% to 25,562.13 points, while the Tech Index fell by 0.24% to 5,664.02 points, and the National Enterprises Index increased by 0.29% to 9,177.15 points [2][3]. Hang Seng Index Movement - The Hang Seng Index reached a high of 25,660.54 points in the morning but maintained a volatile pattern before closing slightly higher [4]. Sector Performance - Insurance, pharmaceuticals, and brokerage stocks saw collective strength, while coal, shipping, and photovoltaic stocks experienced adjustments [5]. Insurance Sector Strength - Major insurance stocks like AIA Group (up 4.96%), China Pacific Insurance (up 3.91%), and Ping An Insurance (up 3.49%) saw significant gains due to a favorable assessment of life insurance reserve interest rates, which are expected to lower the new business liability costs for insurers [6][7]. Pharmaceutical Sector Boost - Pharmaceutical stocks surged, with companies like Fonda Holdings (up 10.39%), Zhaoyan New Drug (up 6.76%), and Via Biotechnology (up 5.45%) benefiting from overseas licensing deals, including a notable $12.5 billion collaboration between Hengrui Medicine and GlaxoSmithKline [8][9]. Brokerage Sector Gains - Brokerage stocks such as Guotai Junan International (up 9.45%), Shenwan Hongyuan Hong Kong (up 7.32%), and Xingzheng International (up 5.08%) experienced strong performance, likely influenced by the upcoming implementation of the Stablecoin Regulation in Hong Kong [11][13]. Weakness in Cyclical Stocks - Coal, shipping, and photovoltaic stocks faced declines, with companies like Feishang Non-Ferrous Coal (down 15.28%) and COSCO Shipping Ports (down 10.99%) leading the downturn due to falling commodity prices in the futures market [14][18]. Individual Stock Movements - Xuanwu Cloud saw a significant increase of 28% following a strategic partnership with LG Uplus, while Zhejiang United Investment surged by 116.67% on expectations of turning a profit by April 2025 [23][24].